Trojanowski Justin has filed 6 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 22000 shares of Tempest Therapeutics, Inc. ($TPST) on March 31, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Tempest Therapeutics, Inc. | $TPST | Trojanowski Justin | Corporate Controller | A | Employee Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 4,440,161 | 9999.99% | 0.50% |
| Jan. 2, 2025 | Tempest Therapeutics, Inc. | $TPST | Trojanowski Justin | Corporate Controller | A | Employee Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Tempest Therapeutics, Inc. | $TPST | Trojanowski Justin | Corporate Controller | P | Common Stock | 7500 | $2.16 | 22,168.0000 | 0 | 51.13% | 0.00% |
| Jan. 3, 2024 | Tempest Therapeutics, Inc. | $TPST | Trojanowski Justin | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 26500 | $0.00 | 26,500.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2023 | Tempest Therapeutics, Inc. | $TPST | Trojanowski Justin | Corporate Controller | A | Employee Stock Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Tempest Therapeutics, Inc. | $TPST | Trojanowski Justin | Corporate Controller | A | Employee Stock Option (right to buy) | 20300 | $0.00 | 20,300.0000 | 0 | 9999.99% | 0.00% |